OpenVSafe by OpenVAERS
Search V-safe

FQ3-16565-99735

4 vaccinations 6 coded responses 21 check-ins 6 free-text entries 3 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
031 / NH
Registered
2021-04-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-30
    Registered in v-safe
  3. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-30
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  9. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-05-07
    Survey response — day 7, dose 2
    MedDRA: Anxiety, Fatigue, Impaired work ability — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Fatigue is still happening after one week post second shot. Gets overwhelming to where I have to stop what I'm doing and close my eyes. Not getting better as each day goes by. It's interfering with my ability to function.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-28
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-08-02
    Survey response — 3 months, dose 2
    MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school
    Free text: Possible hypothyroid problem.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  17. 2021-10-29
    Survey response — 6 months, dose 2
    MedDRA: Hypothyroidism, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Hypothyroidism. · Healthcare visit (other): PCP office
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-10-29
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-11-03
  20. 2021-12-03
    Dose 3 — Pfizer-BioNTech
  21. 2022-04-02
    Dose 4 — Pfizer-BioNTech
  22. 2022-04-30
    Survey response — 12 months, dose 2
    MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Developed allergy induced asthma.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-04-30
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  24. 2022-05-02
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  25. 2022-05-03
  26. 2022-05-07
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  27. 2022-05-14
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-07-02
    Survey response — 3 months, dose 4
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: Allergy induced asthma.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-10-01
    Survey response — 6 months, dose 4
    MedDRA: COVID-19, Sinusitis, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: I contracted COVID. · Healthcare visit (other): Contracted an upper respiratory and sinus infection after having COVID.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-10-01
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  31. 2022-10-06
  32. 2023-04-02
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-30Pfizer-BioNTech
32021-12-03Pfizer-BioNTech No
42022-04-02Pfizer-BioNTech No

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 8 — day 7, dose 2

2021-05-07

Systemic reaction (other): Fatigue is still happening after one week post second shot. Gets overwhelming to where I have to stop what I'm doing and close my eyes. Not getting better as each day goes by. It's interfering with my ability to function.

Release 9 — 3 months, dose 2

2021-08-02

Symptoms: Possible hypothyroid problem.

Release 10 — 6 months, dose 2

2021-10-29

Symptoms: Hypothyroidism.
Healthcare visit (other): PCP office

Release 11 — 12 months, dose 2

2022-04-30

Symptoms: Developed allergy induced asthma.

Release 12 — 3 months, dose 4

2022-07-02

Symptoms: Allergy induced asthma.

Release 12 — 6 months, dose 4

2022-10-01

Symptoms: I contracted COVID.
Healthcare visit (other): Contracted an upper respiratory and sinus infection after having COVID.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOCOVID-19 · · ✓
HCVOOffice visit · · ✓
HCVOSinusitis · · ✓
HCVOUpper respiratory tract infection · · ✓
SDAsthma · · ✓
SDCOVID-19 · · ✓
SDHypothyroidism · · ✓
SDPre-existing disease · · ✓
SDUnevaluable event ✓ · ✓
SROAnxiety ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROImpaired work ability ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release